Pre-order Enquiry
Request Free Sample
Global Neurothrombectomy Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-13814153 | Publishing Date : 05-Feb-2019 | No. of pages : 121
A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to retrieve or destroy blood clots in the cerebral neurovasculature.
Scope of the Report:
The global average price of Neurothrombectomy Devices is in the decreasing trend, from 943 USD/Unit in 2012 to938 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Neurothrombectomy Devices includes Retriever and Integrated System, and the proportion of Retriever in 2016 is about 92%.
Neurothrombectomy Devices is widely used in hospitals, clinics and other place. The most proportion of Neurothrombectomy Devices is used in hospitals, and the proportion in 2016 is 72%.
Germany is the largest consumption place in Europe, with a consumption market share nearly 18% in 2016. Following Germany, UK and France is the following two regions consumption place with the consumption market share of 13.89 and 13.87%, respectively.
Market competition is not intense. Stryker Corporation, Medtronic, Penumbra, Phenox, Acandis GmbH, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Neurothrombectomy Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Neurothrombectomy Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Stryker Corporation
Medtronic
Penumbra
Phenox
Acandis GmbH
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Retriever
Integrated System
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurothrombectomy Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neurothrombectomy Devices, with price, sales, revenue and global market share of Neurothrombectomy Devices in 2017 and 2018.
Chapter 3, the Neurothrombectomy Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurothrombectomy Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Neurothrombectomy Devices market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Neurothrombectomy Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
The global average price of Neurothrombectomy Devices is in the decreasing trend, from 943 USD/Unit in 2012 to938 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Neurothrombectomy Devices includes Retriever and Integrated System, and the proportion of Retriever in 2016 is about 92%.
Neurothrombectomy Devices is widely used in hospitals, clinics and other place. The most proportion of Neurothrombectomy Devices is used in hospitals, and the proportion in 2016 is 72%.
Germany is the largest consumption place in Europe, with a consumption market share nearly 18% in 2016. Following Germany, UK and France is the following two regions consumption place with the consumption market share of 13.89 and 13.87%, respectively.
Market competition is not intense. Stryker Corporation, Medtronic, Penumbra, Phenox, Acandis GmbH, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Neurothrombectomy Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Neurothrombectomy Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Stryker Corporation
Medtronic
Penumbra
Phenox
Acandis GmbH
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Retriever
Integrated System
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurothrombectomy Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neurothrombectomy Devices, with price, sales, revenue and global market share of Neurothrombectomy Devices in 2017 and 2018.
Chapter 3, the Neurothrombectomy Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurothrombectomy Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Neurothrombectomy Devices market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Neurothrombectomy Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
